pulmonary fibrosis

June 2, 2017June 2, 2017

Lung Cell Regeneration Research Wins $6.9 Million NIH Grant

Research focused on lung cell regeneration processes has been awarded a $6.9 million, seven-year grant by the National Institutes of Health (NIH) National Heart, Lung and Blood Institute (NHLBI), potentially ... Read more

May 15, 2017May 15, 2017

New York Researchers Create Lung-in-a-Dish Model to Study Respiratory Diseases

Idiopathic Pulmonary Fibrosis, News

A Columbia University Medical Center team has created a three-dimensional structure similar to a lung to help scientists do a better job of studying respiratory diseases, according to a study. They cultured ... Read more

May 5, 2017May 5, 2017

Artificially Produced Cells Could Boost Lung Disease Research, Study Says

Idiopathic Pulmonary Fibrosis

Cells can be artificially produced that have many features of those found in human lung cells, researchers report. To do this, they identified the genetic program that regulates the formation ... Read more

April 14, 2017April 18, 2017

4 Breathing Mistakes You’re Probably Making

We breathe every day. For some of us, this process is simple and we don’t think too much about it. For others, it’s a constant struggle that requires a lot ... Read more

April 12, 2017April 13, 2017

Researchers Develop New Probe to Follow PF Progression, Treatment

Idiopathic Pulmonary Fibrosis, News

Researchers developed a new probe to use in positron emission tomography (PET) imaging that may help diagnose and monitor pulmonary fibrosis, according to a study. The probe, called 68Ga-CBP8, binds ... Read more

April 11, 2017April 11, 2017

Researchers Review Performance of Genentech’s Esbriet in Treating Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis, News

Genentech’s Esbriet (pirfenidone), approved by the U.S. Food and Drug Administration (FDA) in 2014 to treat idiopathic pulmonary fibrosis (IPF), prolongs survival in patients and is generally safe, concludes a review, “Role ... Read more

March 30, 2017March 30, 2017

Kadmon’s Preclinical Findings Support ROCK Inhibition as Potential PF Therapy

Idiopathic Pulmonary Fibrosis, News

Kadmon Holdings reported preclinical findings showing the significance of the ROCK signaling pathway in the development of pulmonary fibrosis (PF), supporting the development of drugs that inhibit this pathway as a ... Read more

March 7, 2017March 7, 2017

Treatment Seen to Lessen Fibrotic Scarring That Causes Lung Transplants to Fail

Bronchiolitis, COPD, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, News

Treatment may be able prevent the progressive accumulation of scar tissue (fibrosis) in newly transplanted lungs that eventually cause those organs to fail, researchers at the University of Michigan report. The study, “Autocrine lysophosphatidic ... Read more

February 10, 2017February 10, 2017

New Genetic Risk Markers for COPD Seen to Overlap with Other Lung Diseases

COPD, News

New genetic markers have been found for chronic obstructive pulmonary disease (COPD), according to a large research study, which included more than 15,000 COPD patients. Some of the risk genes for COPD were ... Read more

November 18, 2016November 18, 2016

ProMetic’s Therapy Improved Fibrosis, Cardiac Function in Mice with Heart Failure

News, Pulmonary Hypertension

ProMetic Life Science’s fibrosis-targeting investigational drug PBI-4050 improved pulmonary hypertension (PH), lung remodeling and right ventricular function in mice with heart failure. PBI-4050 also decreased biomarkers for heart disease in patients with ... Read more